Table II.
Proliferation stage/tissue remodeling stage | ||||
---|---|---|---|---|
Gene | Control samples | P-value | HS | P-value |
Wnt2B | 3.371 | 0.032 | - | - |
Wnt-5 | 4.348 | 0.000 | 2.941 | 0.014 |
SFRP4 | 0.0267 | 0.000 | 0.140 | 0.013 |
DACT2 | 0.071 | 0.000 | - | - |
SFRP4, secreted frizzled-related protein 4; DACT2, dishevelled-binding antagonist of β-catenin 2; -, undetected differential expression; HS, hypertrophic scarring.